Novartis Ag Adr Stock Widgets and Gadgets
| NVS Stock | USD 97.73 0.46 0.47% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- NVS Novartis AG ADR
- Latest Appian Corporation Q1 2024 Earnings Call Transcript
- NVS 97.73 0.46
- Low 97.07
- High 97.91
- Alpha -0.0699
- Beta 0.41
- Return On Equity 0.2
- Return On Asset 0.0865
- Profit Margin 0.32 %
- Operating Margin 0.31 %
- Current Valuation 216.13 B
- Shares Outstanding 2.04 B
- Shares Owned By Institutions 6.94 %
- Number Of Shares Shorted 3.81 M
- Price To Earning 9.22 X
- Price To Book 4.10 X
- Price To Sales 4.14 X
- Revenue 46.66 B
- Gross Profit 36.74 B
- EBITDA 18.47 B
- Net Income 8.57 B
- Cash And Equivalents 4.64 B
- Cash Per Share 8.84 X
- Total Debt 26.35 B
- Debt To Equity 0.47 %
- Current Ratio 1.31 X
- Book Value Per Share 19.45 X
- Cash Flow From Operations 14.46 B
- Short Ratio 2.35 X
- Earnings Per Share 4.40 X
- Price To Earnings To Growth 5.09 X
- Target Price 114.51
- Number Of Employees 76.06 K
- Beta 0.48
- Market Capitalization 198.47 B
- Total Asset 99.94 B
- Retained Earnings 49.65 B
- Working Capital 4.09 B
- Current Asset 22.84 B
- Current Liabilities 23.71 B
- Annual Yield 0.04 %
- Five Year Return 3.53 %
- Net Asset 99.94 B
- Last Dividend Paid 3.92
- Accumulation Distribution 0.0086
- Daily Balance Of Power 0.5476
- Rate Of Daily Change 1.0
- Day Median Price 97.49
- Day Typical Price 97.57
- Market Facilitation Index 0.84
- Price Action Indicator 0.47
- Period Momentum Indicator 0.46
Market Snapshot Widget Example
DAX Index Germany | 18,002 0.59 | |
Taiwan Weighted Taiwan | 20,330 0.53 | |
PSI 20 Stock Portugal | 6,649 0.25 | |
CROBEX Croatia | 2,814 0.05 | |
Budapest SE Hungary | 68,002 0.18 | |
IDX 30 Jakarta Indonesia | 457.92 0.50 | |
ISEQ 20 Price Ireland | 1,678 0.13 | |
NYSE Comp USA | 17,798 0.56 | |
Tel Aviv 35 Israel | 1,939 0.46 | |
Coreshares Index Tracker South Afric | 1,056 0.96 | |
IPC MEXICO Mexico | 57,135 0.81 | |
KL Technology Malaysia | 65.57 1.24 | |
IBEX 35 Index Spain | 10,855 0.16 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,591 0.02 | |
SPASX Dividend Opportunities Australia | 1,645 0.67 | |
HNX 30 Vietnam | 490.71 0.51 | |
Bucharest BET-NG Romania | 1,231 0.64 | |
AMS Small Cap Netherlands | 1,172 0.64 | |
Oslo Exchange Mutual Norway | 1,323 0.57 | |
BEL Small Belgium | 9,061 0.52 | |
RTSI Index Russia | 1,185 0.66 | |
Basic Materials Brazil | 5,890 1.82 | |
Swiss Leader Price Switzerland | 1,848 0.83 | |
Fondo Mutuo ETF Chile | 1,436 0.71 | |
Athens General Comp Greece | 1,452 0.35 | |
Stock Exchange Of Thailand | 1,370 0.49 | |
PX Prague Stock Czech Repub | 1,555 0.43 | |
THE PHILIPPINE STOCK Philippines | 6,616 0.47 | |
WIG 30 Poland | 3,063 0.58 | |
BIST Electricity Turkey | 610.92 0.19 |
Investing Ideas
In addition to having Novartis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Novartis
Compare Novartis To Peers
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novartis AG ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Novartis Stock analysis
When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.215 | Dividend Share 3.919 | Earnings Share 4.4 | Revenue Per Share 23.168 | Quarterly Revenue Growth 0.097 |
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.